140 related articles for article (PubMed ID: 24856055)
1. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
[TBL] [Abstract][Full Text] [Related]
2. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse.
Rahn DD; Richter HE; Sung VW; Hynan LS; Pruszynski JE
Am J Obstet Gynecol; 2023 Sep; 229(3):309.e1-309.e10. PubMed ID: 37244454
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.
Gueldini de Moraes AV; Costa-Paiva L; da Costa Machado H; Maciel TF; Mariano FV; Pedro AO
Menopause; 2024 Apr; 31(4):288-302. PubMed ID: 38412393
[TBL] [Abstract][Full Text] [Related]
4. Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials.
Kagan R; Simon JA; Goldstein SR; Komm BS; Jenkins SN; Portman DJ
Menopause; 2024 Jun; 31(6):494-504. PubMed ID: 38652875
[TBL] [Abstract][Full Text] [Related]
5. Microablative fractional radiofrequency for sexual dysfunction and vaginal Trophism: A randomized clinical trial.
Sarmento ACA; Fernandes FS; Maia RR; de Araújo Santos Camargo JD; de Oliveira Crispim JC; Eleutério Júnior J; Gonçalves AK
Clinics (Sao Paulo); 2023; 78():100293. PubMed ID: 37839177
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: an updated systematic review and meta-analysis.
Farahat RA; Salamah HM; Mahmoud A; Hamouda E; Hashemy M; Hamouda H; Samir A; Chenfouh I; Marey A; Awad DM; Farag E; Abd-Elgawad M; Eldesouky E
BMC Womens Health; 2023 Sep; 23(1):494. PubMed ID: 37716966
[TBL] [Abstract][Full Text] [Related]
7. The effect of soy isoflavones in brain development: the emerging role of multiple signaling pathways and future perspectives.
Ariyani W; Koibuchi N
Endocr J; 2024 Apr; 71(4):317-333. PubMed ID: 38346749
[TBL] [Abstract][Full Text] [Related]
8. A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.
Carter J; Goldfarb S; Baser RE; Goldfrank DJ; Seidel B; Milli L; Saban S; Stabile C; Canty J; Gardner GJ; Jewell EL; Sonoda Y; Kollmeier MA; Alektiar KM
Gynecol Oncol; 2020 Aug; 158(2):366-374. PubMed ID: 32522420
[TBL] [Abstract][Full Text] [Related]
9. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy.
Kingsberg S; Kellogg S; Krychman M
Int J Womens Health; 2010 Aug; 1():105-11. PubMed ID: 21072280
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial.
Gustavino C; Sala P; Cusini N; Gravina B; Ronzini C; Marcolin D; Vellone VG; Paudice M; Nappi R; Costantini S; Ferrero S; Barra F
Ann Med; 2021 Dec; 53(1):1589-1597. PubMed ID: 34477473
[TBL] [Abstract][Full Text] [Related]
11. Cellular and extracellular vaginal changes following murine ovarian removal.
McCracken JM; Calderon GA; Le QN; Faruqui NM; Balaji S; Hakim JCE
Physiol Rep; 2023 Aug; 11(15):e15762. PubMed ID: 37549960
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency.
Joris A; Di Pietrantonio V; Praet J; Renard K; Verduyn AC; Buxant F; Rozenberg S
Climacteric; 2024 Apr; 27(2):210-214. PubMed ID: 38251861
[TBL] [Abstract][Full Text] [Related]
13. Reviewing the options for local estrogen treatment of vaginal atrophy.
Lindahl SH
Int J Womens Health; 2014; 6():307-12. PubMed ID: 24648775
[TBL] [Abstract][Full Text] [Related]
14. The Comparative Study of the Administration of the Combination Preparation of Isoflavones and Hyaluronic Acid in Menopausal Women for the Treatment of the Symptoms of Menopause, Urogenital Atrophy and Oteoporosis in Relation to Existing Hormone Replacement Therapies.
Chalkidou A; Oikonomou E; Lambrinos D; Bothou A; Kyriakou D; Nikolettos K; Marinos G; Iatrakis G; Zervoudis S; Nikolettos N; Tsikouras P
Mater Sociomed; 2023 Sep; 35(3):206-214. PubMed ID: 37795159
[TBL] [Abstract][Full Text] [Related]
15. Using Wood's Light as a Diagnostic Tool for Vaginal Atrophy.
Ulubay M; Ozturk M; Fidan U; Keskin U; Alanbay I; Karaca R
J Clin Diagn Res; 2015 Jan; 9(1):QC05-8. PubMed ID: 25738039
[TBL] [Abstract][Full Text] [Related]
16. Vaginal Estrogen Therapy for Patients with Breast Cancer.
Moegele M; Buchholz S; Seitz S; Lattrich C; Ortmann O
Geburtshilfe Frauenheilkd; 2013 Oct; 73(10):1017-1022. PubMed ID: 24771890
[TBL] [Abstract][Full Text] [Related]
17. Topical administration of isoflavones for treatment of vaginal symptoms in postmenopausal women: A systematic review of randomised controlled trials.
Ghazanfarpour M; Latifnejad Roudsari R; Treglia G; Sadeghi R
J Obstet Gynaecol; 2015; 35(8):783-7. PubMed ID: 25710207
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D on vaginal atrophy in postmenopausal women.
Rad P; Tadayon M; Abbaspour M; Latifi SM; Rashidi I; Delaviz H
Iran J Nurs Midwifery Res; 2015; 20(2):211-5. PubMed ID: 25878698
[TBL] [Abstract][Full Text] [Related]
19. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women.
Tersigni C; Di Simone N; Tempestilli E; Cianfrini F; Russo R; Moruzzi MC; Amar ID; Fiorelli A; Scambia G; Villa P
J Obstet Gynaecol; 2015; 35(8):835-8. PubMed ID: 25968636
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
